Total Visits
| Views | |
|---|---|
| Afatinib ... | 39 |
Total Visits Per Month
| June 2023 | July 2023 | August 2023 | September 2023 | October 2023 | November 2023 | December 2023 | |
|---|---|---|---|---|---|---|---|
| Afatinib ... | 1 | 1 | 0 | 0 | 0 | 2 | 0 |
File Visits
| Views | |
|---|---|
| afatinib_versus_erlotinib_as_second_line_treatment_patients_advanced_squamous_cell_carcinoma_lung_final_analysis_randomised_phase_3_lux_lung_8_trial_2021.pdf | 13 |
| afatinib_versus_erlotinib_as_second_line_treatment_patients_advanced_squamous_cell_carcinoma_lung_final_analysis_randomised_phase_3_lux_lung_8_trial_2021_material_suplementari2.pdf | 7 |
| afatinib_versus_erlotinib_as_second_line_treatment_patients_advanced_squamous_cell_carcinoma_lung_final_analysis_randomised_phase_3_lux_lung_8_trial_2021_material_suplementari3.pdf | 6 |
| afatinib_versus_erlotinib_as_second_line_treatment_patients_advanced_squamous_cell_carcinoma_lung_final_analysis_randomised_phase_3_lux_lung_8_trial_2021_material_suplementari1.pdf | 5 |
Top country views
| Views | |
|---|---|
| United States | 18 |
| China | 3 |
| Spain | 3 |
| Japan | 3 |
| Austria | 2 |
| Germany | 2 |
| France | 2 |
| Sweden | 2 |
| Belgium | 1 |
| United Kingdom | 1 |
Top cities views
| Views | |
|---|---|
| Ashburn | 2 |
| Barcelona | 2 |
| Chiyoda | 2 |
| Phoenix | 2 |
| Vienna | 2 |
| Amsterdam | 1 |
| Belfast | 1 |
| Brussels | 1 |
| Chandler | 1 |
| Dublin | 1 |